Trials / Active Not Recruiting
Active Not RecruitingNCT05566262
Bodewell Products for the Treatment of Atopic Dermatitis
An Investigator Initiated Open-label Study Evaluating the Efficacy and Tolerability of Application of Bodewell Products for the Treatment of Atopic Dermatitis
- Status
- Active Not Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to examine the safety and efficacy of topical application of the Bodewell eczema products
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bodewell Calming Cream | Bodewell is a non-prescription and contains 22 botanical ingredients in addition to colloidal oatmeal. |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2027-02-01
- Completion
- 2028-02-01
- First posted
- 2022-10-04
- Last updated
- 2026-03-02
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05566262. Inclusion in this directory is not an endorsement.